Search Results 1191-1200 of 17025 for monoclonal antibody
Finally, structural compatibility problems are avoided between ligands and vector proteins such that large ligands (for example, antibodies) and nonprotein ...
Patients who have had a prior monoclonal antibody within 4 weeks prior to study day 1 are not eligible. Patients with a known additional malignancy that is ...
For Follicular Lymphoma, patients must have received prior chemoimmunotherapy including an antibody directed against CD20. For Mantle Cell Lymphoma ...
Monoclonal antibody; T cell vaccination; Cladribine; Bone marrow transplantation; Azathioprine; Cyclophosphamide; Methotrexate; Mitoxantrone; Cyclosporin ...
... monoclonal antibodies, other investigational agent) < 28 days prior to the first dose of study drug. Current or prior use of immunosuppressive medication ...
... antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma. Participation eligibility.
GSK3511294 (long-acting anti-IL-5) in the past 12 months. 5. Treatment with any of the following monoclonal antibody therapies within 120 days prior to ...
... antibodies and the factors that may determine disease progression and treatment response. Safety/Efficacy of MEDI-551 in Combination With Immunomodulating ...
Documented to be RSV-positive as determined by local testing (eg, polymerase chain reaction, direct fluorescence antibody ... monoclonal anti-RSV antibodies ...
Prior known hypersensitivity reactions to monoclonal antibodies (≥ Grade 3). Prior known hypersensitivity reactions to study drugs and/or any of their ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.